Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inhaler
Manufacturing
Lupin to lay out $250M for new Fla. manufacturing facility
Indian pharma juggernaut Lupin—best known in the U.S. for its portfolio of generic drugs—is laying down new manufacturing roots in Florida.
Fraiser Kansteiner
Oct 9, 2025 9:02am
Chiesi unveils €430M investment in new Italian inhaler facility
Mar 27, 2025 10:47am
AZ pads data package for Airsupra in patients with milder asthma
Oct 7, 2024 2:40pm
FTC launches investigation into Teva's inhaler patents: report
Jul 2, 2024 10:02am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
FTC blasts Teva for 'improper' inhaler patents
Mar 25, 2024 10:04am
